Is Lonza Group (LZAGY) Stock Halal?
Compliance Status
Halal
Screened on Oct 28, 2026 · AAOIFI Standard 21
Very Good
Is Lonza Group AG (LZAGY) halal? Halal. Based on AAOIFI screening, Lonza Group AG passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 87/100 (Grade: A).
Quote this verdict
HalalScreener rates Lonza Group AG (LZAGY) Halal, 87/100, grade A under AAOIFI Standard 21, screened Oct 28, 2026. Source: https://halalscreener.app/en/stock/LZAGY
Business activity
What the company sells is permissible.
Company debt
Well clear of the limitHow much the company borrows, compared to its total value. AAOIFI allows up to 30%.
The verdict above is final and free.
Pro members can verify every number behind it: interest-bearing deposits, prohibited income breakdown, and the full AAOIFI math.
Screened according to AAOIFI Standard 21
What this means for you
You can own LZAGY
It passes both the business activity and financial ratio screens under AAOIFI Standard 21.
Purification amount is Pro
We have screened LZAGY's prohibited income, but the exact share you would need to purify is part of Pro.
See plansShare this verdict
A receipt-style image with the math on it, so whoever you send it to can check it.

LZAGY
Lonza Group AG
$77.84
Market Cap: 55.4B
Screened on a market cap of 44.4B
Get an email if LZAGY's halal status changes
We re-screen Lonza Group AG daily. If the verdict moves, you hear about it the same day.
Free. One click sets it up, and you can unsubscribe any time.
About Lonza Group AG
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment design, development, and manufacturing, with the ability to offer integrated drug substances to drug product solutions, including particle engineering and drug product packaging. The Cell and Gene segment develops, de-risk, commercializes, and scales their emerging therapies through its three business areas Cell and Gene Technologies, Bioscience, and Personalized Medicine. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.
Sector: Healthcare · Industry: Biotechnology
Shariah Compliance Status
Compliance History
Halal, unchanged since Jun 2026.
No status changes recorded since we began tracking.
Tracked since Jun 2026. Updates automatically on each re-screen.
More Healthcare Stocks
Know the day LZAGY's verdict changes
A free account keeps watch on 3 stocks and emails you when a verdict moves. You also get 3 questions for the AI Scholar. No card needed.
Frequently Asked Questions
Is Lonza Group AG (LZAGY) halal to invest in?
Why did Lonza Group AG get a A compliance rating?
What could change Lonza Group AG's Shariah verdict?
How often is Lonza Group AG re-screened for Shariah compliance?
Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.
Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.